home / press / releases

Menu
  • Search all tables

releases: https://www.murkowski.senate.gov/press/release/murkowski-comments-on-fda-authorization-of-pfizer-biontech-vaccine

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.murkowski.senate.gov/press/release/murkowski-comments-on-fda-authorization-of-pfizer-biontech-vaccine Murkowski Comments on FDA Authorization of Pfizer-BioNTech Vaccine 2020-12-12 2020 2020-12 Republican House AK Lisa Murkowski M001153 www.murkowski.senate.gov     legacy 12.12.20 Murkowski Comments on FDA Authorization of Pfizer-BioNTech Vaccine U.S. Senator Lisa Murkowski (R-AK) issued the following statement after the U.S. Food and Drug Administration (FDA) granted an emergency use authorization for the Pfizer-BioNTech coronavirus vaccine: The FDA authorized the Pfizer vaccine to combat COVID-19, meaning administration of the first doses for frontline health workers and long-term care facility residents in Alaska could begin as soon as next week. This is a major milestone in the fight against the pandemic, said Senator Murkowski. In the midst of the holiday season, adhering to the changes that COVID-19 requires of us is increasingly difficult. But, as the rollout of a nationwide vaccine distribution plan begins, it is as important as ever that all Alaskansall Americanscontinue to follow public health guidelines, including social distancing, avoiding large gatherings, wearing masks, and washing your hands. This announcement is good progress, but this is just the first step in a long journey back to normal'. As we navigate this phase of recovery, the best gift we can give each other is to continue our efforts to protect the health and safety of ourselves and others. Print Email Tweet 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 0.679ms · Data license: MIT · Data source: dwillis/congress-press